It’s high time we took a breath from marijuana commercialization By BOB TROYER | Guest Commentary September 28, 2018 at 4:51 pm In 2012 we were told Colorado would lead the nation on a grand experiment in commercialized marijuana. Six years later – with two major industry reports just released and the state legislature and Denver City Council about to consider more expansion measures – it’s a perfect time to pause and assess some results of that experiment. Where has our breathless sprint into full-scale marijuana commercialization led Colorado? Well, recent reports from the Rocky Mountain High Intensity Drug Trafficking Area, from Denver Health, from Energy Associates, from the Colorado Department of Revenue and from the City of Denver should be enough to give everyone in this race pause. Now Colorado’s youth use marijuana at a rate 85 percent higher than the national average. Now marijuana-related traffic fatalities are up by 151 percent. Now 70 percent of 400 licensed pot shops surveyed recommend that pregnant women use marijuana to treat morning sickness. Now an indoor marijuana grow consumes 17 times more power per square foot than an average residence. Now each of the approximately one million adult marijuana plants grown by licensed growers in Colorado consumes over 2.2 liters of water – per day. Now Colorado has issued over 40 little-publicized recalls of retail marijuana laced with pesticides and mold. And now Colorado has a booming black market exploiting our permissive regulatory system – including Mexican cartel growers for that black market who use nerve-agent pesticides that are contaminating Colorado’s soil, waters, and wildlife. Marijuana commercialization has led Colorado to these places. It also has led to Colorado’s prominence in other states considering commercialization. As the U.S. attorney leading other U.S. attorneys on marijuana issues, I have traveled the country and heard what people are saying about Colorado. Do they tout Colorado’s tax revenue from commercialized marijuana? No, because there’s been no net gain:  marijuana tax revenue adds less than one percent to Colorado’s coffers, which is more than washed out by the public health, public safety, and regulatory costs of commercialization. Do they highlight commercialization’s elimination of a marijuana black market? No, because Colorado’s black market has actually exploded after commercialization: we have become a source-state, a theater of operation for sophisticated international drug trafficking and money laundering organizations from Cuba, China, Mexico, and elsewhere. Do they promote our success in controlling production or containing marijuana within our borders?  No, because last year alone the regulated industry produced 6.4 metric tons of unaccounted-for marijuana, and over 80,000 black market plants were found on Colorado’s federal lands. Does the industry trumpet its promised decrease in alcohol use? No, because Colorado’s alcohol consumption has steadily climbed since marijuana commercialization. How about the industry’s claim that marijuana will cure opioid addiction? No, a Lancet study found that heavy marijuana users end up with more pain and are more likely to abuse opioids. Yet on that last point, the marijuana industry is trying to exploit our nation’s opioid tragedy to push its own controlled substance as a panacea. Why? It’s a profit opportunity. Which is also how they see our youth. Which is why in Colorado they now sell marijuana-consumption devices that avoid detection at schools, like vape pens made to look like high-lighters and eye-liner. These are the same marketers who advertise higher and higher potency marijuana gummi candy, marijuana suppositories, and marijuana “intimate creams.” This aggressive marketing makes perfect sense in addiction industries like tobacco, alcohol, opioids, and marijuana. These industries make the vast majority of their profits from heavy users, and so they strive to create and maintain this user market. Especially when users are young and their brains are most vulnerable to addiction. I’m not sure the 55 percent of Coloradans who voted for commercialization in 2012 thought they were voting for all this. These impacts are why you may start seeing U.S. attorneys shift toward criminally charging licensed marijuana businesses and their investors. After all, a U.S. attorney is responsible for public safety. My office has always looked at marijuana solely through that lens, and that approach has not changed. But the public safety impacts of marijuana in Colorado have. Now that federal enforcement has shot down marijuana grows on federal lands, the crosshairs may appropriately shift to the public harms caused by licensed businesses and their investors, particularly those who are not complying with state law or trying to use purported state compliance as a shield. We should pause and catch our breath before racing off again at the industry’s urging. Let’s call it “just say know.” Let’s educate ourselves about the impacts of commercialization. Let’s reclaim our right as citizens to have a say in Colorado’s health, safety, and environment. Unfettered commercialization is not inevitable. You have a say. Bob Troyer became the U.S. attorney for the District of Colorado in 2016 after working as first assistant U.S. attorney for six years. https://learnaboutsam.org/

Americans struggling with addiction need treatment and reduced access to deadly drugs. They do not need a taxpayer-sponsored haven to shoot up.

https://www.nytimes.com/2018/08/27/opinion/opioids-heroin-injection-sites.html

Fight Drug Abuse, Don’t Subsidize It!

-By Rod J. Rosenstein
Mr. Rosenstein is the deputy attorney general of the United States.